“…Other reported sites include the larynx, palate, orbits, sella, nasopharynx, lymph nodes, tracheobronchial tree, and abdominal wall. 10,14,[16][17][18][19][20] Patients with primary localized amyloidoma have no documented risk for the development of myeloma and no evidence of an increased mortality. In contrast, patients with systemic amyloidosis and myeloma have a markedly reduced life expectancy.…”